- Home
- Publications
- Publication Search
- Publication Details
Title
β2-Agonist Therapy in Lung Disease
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 187, Issue 7, Pages 690-696
Publisher
American Thoracic Society
Online
2013-01-25
DOI
10.1164/rccm.201209-1739pp
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
- (2012) Jørgen Vestbo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists
- (2012) David A Sykes et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Efficacy and Safety of the Novel Long-Acting β 2 Agonist Vilanterol in Patients With COPD
- (2012) Nicola A. Hanania et al. CHEST
- 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids
- (2012) Jan Lötvall et al. EUROPEAN RESPIRATORY JOURNAL
- An update on bronchodilators in Phase I and II clinical trials
- (2012) Mario Cazzola et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease
- (2012) Maureen P.M.H. Rutten-van Mölken et al. PHARMACOECONOMICS
- cAMP regulation of airway smooth muscle function
- (2012) Charlotte K. Billington et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial
- (2012) Richard Sterling et al. RESPIRATORY MEDICINE
- Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial
- (2012) J Lötvall et al. BMJ Open
- Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes
- (2012) Thys van der Molen et al. Primary Care Respiratory Journal
- Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial
- (2012) Amanda Oliver et al. Clinical and Translational Allergy
- β2-adrenoceptor agonists: current and future direction
- (2011) Mario Cazzola et al. BRITISH JOURNAL OF PHARMACOLOGY
- Novel cAMP signalling paradigms: therapeutic implications for airway disease
- (2011) Charlotte K Billington et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-term Safety and Efficacy of Indacaterol, a Long-Acting β 2 -Agonist, in Subjects With COPD
- (2011) Kenneth R. Chapman et al. CHEST
- Approaches to stepping up and stepping down care in asthmatic patients
- (2011) Alex Thomas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis
- (2011) J. Wang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Functional and Biochemical Rationales for the 24-Hour-Long Duration of Action of Olodaterol
- (2011) P. Casarosa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development
- (2011) Fernando J Martinez et al. LANCET
- 24-hour Bronchodilation following a single dose of the novel β2-agonist olodaterol in COPD
- (2011) J.A. van Noord et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Tremor and β2-adrenergic agents: Is it a real clinical problem?
- (2011) Mario Cazzola et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Cost-utility analysis of indacaterol in Germany: A once-daily maintenance bronchodilator for patients with COPD
- (2011) David Price et al. RESPIRATORY MEDICINE
- Safety of long-acting β agonists for the treatment of asthma: clearing the air
- (2011) Gustavo J Rodrigo et al. THORAX
- Novel bronchodilators for the treatment of chronic obstructive pulmonary disease
- (2011) Maria Gabriella Matera et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Formoterol for acute asthma in the emergency department: a systematic review with meta-analysis
- (2010) Gustavo J. Rodrigo et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Salmeterol use and risk of hospitalization among emergency department patients with acute asthma
- (2010) Michael M. Liao et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Long-acting 2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD
- (2010) F. de Vries et al. EUROPEAN RESPIRATORY JOURNAL
- Long-Acting Beta-Agonists and Asthma Death: How Useful Are Different Study Designs to Evaluate the Potential Association?
- (2010) Mark Weatherall et al. JOURNAL OF ASTHMA
- Call for withdrawal of LABA single-therapy inhaler in asthma
- (2010) Richard Beasley et al. LANCET
- Aerosol drug delivery: developments in device design and clinical use
- (2010) Myrna B Dolovich et al. LANCET
- The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD
- (2010) Mario Cazzola et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Agonist efficacy and receptor desensitization: from partial truths to a fuller picture
- (2009) Steven J Charlton BRITISH JOURNAL OF PHARMACOLOGY
- Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties?
- (2009) Dario Lombardi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma
- (2009) Paul M. O'Byrne et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Methodological issues in therapeutic trials of COPD
- (2008) S. Suissa et al. EUROPEAN RESPIRATORY JOURNAL
- Outcomes for COPD pharmacological trials: from lung function to biomarkers
- (2008) M. Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
- Global strategy for asthma management and prevention: GINA executive summary
- (2008) E. D. Bateman et al. EUROPEAN RESPIRATORY JOURNAL
- The impact of inhaled corticosteroid and long-acting β-agonist combination therapy on outcomes in COPD
- (2008) Nicola A. Hanania PULMONARY PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started